IPS Cell Technology-Based Research for the Treatment of Diabetic Nephropathy

Seminars in Nephrology

Volumn 32, Issue 5, 2012, Pages 479-485

  Osafune, Kenji ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

diabetic nephropathy; disease modeling; ES cell, cell therapy; iPS cell

Indexed keywords

ACTIVIN; BONE MORPHOGENETIC PROTEIN; CHYMOSIN; NOTCH2 RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; RETINOIC ACID; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; VASCULOTROPIN RECEPTOR 2; WNT4 PROTEIN; WNT9B PROTEIN; WT1 PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; DIABETIC NEPHROPATHY; EMBRYONIC STEM CELL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DEVELOPMENT; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; THERAPY EFFECT;

ANIMALS; CELL LINEAGE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; REGENERATIVE MEDICINE; TISSUE THERAPY;

EID: 84867384686     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2012.07.011     Document Type: Article

References (70)

1. Andersen A.R., Christiansen J.S., Andersen J.K., Kreiner S., Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 1983, 25:496-501.
2. Krolewski A.S., Warram J.H., Christlieb A.R., Busick E.J., Kahn C.R. The changing natural history of nephropathy in type 1 diabetes. Am J Med 1985, 78:785-794.
3. Borch-Johnsen K., Andersen P.K., Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1985, 28:590-596.
4. Forsblom C., Harjutsalo V., Thorn L.M., Wadén J., Tolonen N., Saraheimo M., et al. Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol 2011, 22:537-544.
5. Rosolowsky E.T., Skupien J., Smiles A.M., Niewczas M., Roshan B., Stanton R., et al. Risk for ESRD in type 1 diabetes remains high despite renoprotection. J Am Soc Nephrol 2011, 22:545-553.
6. Anglani F., Mezzabotta F., Ceol M., Cristofaro R., Del Prete D., D'Angelo A. The regenerative potential of the kidney: what can we learn from developmental biology?. Stem Cell Rev 2010, 6:650-657.
7. Roufosse C., Cook H.T. Stem cells and renal regeneration. Nephron Exp Nephrol 2008, 109:e39-e45.
8. Yokoo T., Ohashi T., Shen J.S., Sakurai K., Miyazaki Y., Utsunomiya Y., et al. Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissues. Proc Natl Acad Sci U S A 2005, 102:3296-3300.
9. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
10. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 1981, 78:7634-7638.
11. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
12. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
13. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
14. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
15. Kiskinis E., Eggan K. Progress toward the clinical application of patient-specific pluripotent stem cells. J Clin Invest 2010, 120:51-59.
16. Murry C.E., Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008, 132:661-680.
17. Lau F., Ahfeldt T., Osafune K., Akutsu H., Cowan C.A. Induced pluripotent stem (iPS) cells: an up-to-the-minute review. F1000. Biol Rep 2009, 1:84.
18. D'Amour K.A., Bang A.G., Eliazer S., Kelly O.G., Agulnick A.D., Smart N.G., et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 2006, 24:1392-1401.
19. Saxen L. Organogenesis of the kidney 1987, Cambridge University Press, Cambridge.
20. Rodriguez C.G., Makori N., Cukierski M.A., Hendrickx A.G. Development of the definitive kidney in the cynomolgus monkey (Macaca fascicularis). J Med Primatol 1996, 25:122-132.
21. Burrow C.R. Regulatory molecules in kidney development. Pediatr Nephrol 2000, 14:240-253.
22. Challen G.A., Martinez G., Davis M.J., Taylor D.F., Crowe M., Teasdale R.D., et al. Identifying the molecular phenotype of renal progenitor cells. J Am Soc Nephrol 2004, 15:2344-2357.
23. Dressler G.R. The cellular basis of kidney development. Annu Rev Cell Dev Biol 2006, 22:509-529.
24. Dressler G.R. Advances in early kidney specification, development and patterning. Development 2009, 136:3863-3874.
25. Mugford J.W., Sipilä P., McMahon J.A., McMahon A.P. Osr1 expression demarcates a multi-potent population of intermediate mesoderm that undergoes progressive restriction to an Osr1-dependent nephron progenitor compartment within the mammalian kidney. Dev Biol 2008, 324:88-98.
26. James R.G., Schultheiss T.M. Bmp signaling promotes intermediate mesoderm gene expression in a dose-dependent, cell-autonomous and translation-dependent manner. Dev Biol 2005, 288:113-125.
27. Osafune K., Nishinakamura R., Komazaki S., Asashima M. In vitro induction of the pronephric duct in Xenopus explants. Dev Growth Differ 2002, 44:161-167.
28. Wellik D.M., Hawkes P.J., Capecchi M.R. Hox11 paralogous genes are essential for metanephric kidney induction. Genes Dev 2002, 16:1423-1432.
29. Carroll T.J., Park J.S., Hayashi S., Majumdar A., McMahon A.P. Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev Cell 2005, 9:283-292.
30. Stark K., Vainio S., Vassileva G., McMahon A.P. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 1994, 372:679-683.
31. Osafune K., Takasato M., Kispert A., Asashima M., Nishinakamura R. Identification of multipotent progenitors in the embryonic mouse kidney by a novel colony-forming assay. Development 2006, 133:151-161.
32. Kobayashi A., Valerius M.T., Mugford J.W., Carroll T.J., Self M., Oliver G., et al. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell 2008, 8:169-181.
33. Cheng H.T., Kim M., Valerius M.T., Surendran K., Schuster-Gossler K., Gossler A., et al. Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development 2007, 134:801-811.
34. Nakai S., Sugitani Y., Sato H., Ito S., Miura Y., Ogawa M., et al. Crucial roles of Brn1 in distal tubule formation and function in mouse kidney. Development 2003, 130:4751-4759.
35. Quaggin S.E., Kreidberg J.A. Development of the renal glomerulus: good neighbors and good fences. Development 2008, 135:609-620.
36. Costantini F., Kopan R. Patterning a complex organ: branching morphogenesis and nephron segmentation in kidney development. Dev Cell 2010, 18:698-712.
37. Michos O., Goncalves A., Lopez-Rios J., Tiecke E., Naillat F., Beier K., et al. Reduction of BMP4 activity by gremlin1 enables ureteric bud outgrowth and GDNF/WNT11 feedback signaling during kidney branching morphogenesis. Development 2007, 134:2397-2405.
38. Grieshammer U., Le M., Plump A.S., Wang F., Tessier-Lavigne M., Martin G.R. SLIT2-mediated ROBO2 signaling restricts kidney induction to a single site. Dev Cell 2004, 6:709-717.
39. Basson M.A., Akbulut S., Watson-Johnson J., Simon R., Carroll T.J., Shakya R., et al. Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction. Dev Cell 2005, 8:229-239.
40. Batchelder C.A., Lee C.C., Martinez M.L., Tarantal A.F. Ontogeny of the kidney and renal developmental markers in the rhesus monkey (Macaca mulatta). Anat Rec (Hoboken) 2010, 293:1971-1983.
41. Metsuyanim S., Harari-Steinberg O., Buzhor E., Omer D., Pode-Shakked N., Ben-Hur H., et al. Expression of stem cell markers in the human fetal kidney. PLoS One 2009, 4:e6709.
42. Yamamoto M., Cui L., Johkura K., Asanuma K., Okouchi Y., Ogiwara N., et al. Branching ducts similar to mesonephric ducts or ureteric buds in teratomas originating from mouse embryonic stem cells. Am J Physiol Renal Physiol 2006, 290:F52-F60.
43. Kobayashi T., Tanaka H., Kuwana H., Inoshita S., Teraoka H., Sasaki S., et al. Wnt4-transformed mouse embryonic stem cells differentiate into renal tubular cells. Biochem Biophys Res Commun 2005, 336:3527-3534.
44. Kim D., Dressler G.R. Nephrogenic factors promote differentiation of mouse embryonic stem cells into renal epithelia. J Am Soc Nephrol 2005, 16:3527-3534.
45. Vigneau C., Polgar K., Striker G., Elliott J., Hyink D., Weber O., et al. Mouse embryonic stem cell-derived embryoid bodies generate progenitors that integrate long term into renal proximal tubules in vivo. J Am Soc Nephrol 2007, 18:1709-1720.
46. Bruce S.J., Rea R.W., Steptoe A.L., Busslinger M., Bertram J.F., Perkins A.C. In vitro differentiation of murine embryonic stem cells toward a renal lineage. Differentiation 2007, 75:337-349.
47. Morizane R., Monkawa T., Itoh H. Differentiation of murine embryonic stem cell and induced pluripotent stem cells to renal lineage in vitro. Biochem Biophys Res Commun 2009, 390:1334-1339.
48. Ren X., Zhang J., Gong X., Niu X., Zhang X., Chen P., et al. Differentiation of murine embryonic stem cells toward renal lineages by conditioned medium from ureteric bud cells in vitro. Acta Biochim Biophys Sin (Shanghai) 2010, 42:464-471.
49. Mae S., Shirasawa S., Yoshie S., Sato F., Kanoh Y., Ichikawa H., et al. Combination of small molecules enhances differentiation of mouse embryonic stem cells into intermediate mesoderm through BMP7-positive cells. Biochem Biophys Res Commun 2010, 393:877-882.
50. Schuldiner M., Yanuka O., Itskovitz-Eldor J., Melton D.A., Benvenisty N. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 2000, 97:11307-11312.
51. Batchelder C.A., Lee C.I., Matsell D.G., Yoder M.C., Tarantal A.F. Renal ontogeny in the rhesus monkey (Macaca mulatta) and directed differentiation of human embryonic stem cells towards kidney precursors. Differentiation 2009, 78:45-56.
52. Yamanaka S. Pluripotency and nuclear reprogramming. Philos Trans R Soc Lond B Biol Sci 2008, 363:2079-2087.
53. Osafune K., Caron L., Borowiak M., Martinez R.J., Fitz-Gerald C.S., Sato Y., et al. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol 2008, 26:313-315.
54. Takayama N., Nishimura S., Nakamura S., Shimizu T., Ohnishi R., Endo H., et al. Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med 2010, 207:2817-2830.
55. Kim K., Doi A., Wen B., Ng K., Zhao R., Cahan P., et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010, 467:285-290.
56. Polo J.M., Liu S., Figueroa M.E., Kulalert W., Eminli S., Tan K.Y., et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 2010, 28:848-855.
57. Bar-Nur O., Russ H.A., Efrat S., Benvenisty N. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell 2011, 9:17-23.
58. Song B., Niclis J.C., Alikhan M.A., Sakkal S., Sylvain A., Kerr P.G., et al. Generation of induced pluripotent stem cells from human kidney mesangial cells. J Am Soc Nephrol 2011, 22:1213-1220.
59. Zhou T., Benda C., Duzinger S., Huang Y., Li X., Li Y., et al. Generation of induced pluripotent stem cells from urine. J Am Soc Nephrol 2011, 22:1221-1228.
60. Chen S., Borowiak M., Fox J.L., Maehr R., Osafune K., Davidow L., et al. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat Chem Biol 2009, 5:258-265.
61. Kobayashi T., Yamaguchi T., Hamanaka S., Kato-Itoh M., Yamazaki Y., Ibata M., et al. Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells. Cell 2010, 142:787-799.
62. Zhou Q., Brown J., Kanarek A., Rajagopal J., Melton D.A. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008, 455:627-632.
63. Panq Z.P., Yang N., Vierbuchen T., Ostermeier A., Fuentes D.R., Yang T.Q., et al. Induction of human neuronal cells by defined transcription factors. Nature 2011, 476:220-223.
64. Dronavalli S., Duka I., Bakris G.L. The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab 2008, 4:444-452.
65. Ezquer F.E., Ezquer M.E., Parrau D.B., Carpio D., Yañez A.J., Conget P.A. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant 2008, 14:631-640.
66. Lee R.H., Seo M.J., Reger R.L., Spees J.L., Pulin A.A., Olson S.D., et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A 2006, 103:17438-17443.
67. Dimos J.T., Rodolfa K.T., Niakan K.K., Weisenthal L.M., Mitsumoto H., Chung W., et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008, 321:1218-1221.
68. Park I.H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., et al. Disease-specific induced pluripotent stem cells. Cell 2008, 134:877-886.
69. Maehr R., Chen S., Snitow M., Ludwig T., Yagasaki L., Goland R., et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A 2009, 106:15768-15773.
70. Pezzolesi M.G., Skupien J., Krolewski A.S. Insights to the genetics of diabetic nephropathy through a genome-wide association study of the GoKinD collection. Semin Nephrol 2010, 30:126-140.